BriteN (Q3989096): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Fix Beneficiary from Netherlands) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
| Property / beneficiary name (string) | |||
Metris BV | |||
| Property / beneficiary name (string): Metris BV / rank | |||
Normal rank | |||
| Property / beneficiary | |||
| Property / beneficiary: Q3985818 / rank | |||
Normal rank | |||
Revision as of 09:24, 16 December 2021
Project Q3989096 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BriteN |
Project Q3989096 in Netherlands |
Statements
818,513.44 Euro
0 references
4,999,229.47 Euro
0 references
16.373 percent
0 references
1 January 2016
0 references
31 March 2021
0 references
Artinis Medical systems BV
0 references
Green Dino BV
0 references
Mead Johnson Nutrition Innovation Services BV
0 references
Metris BV
0 references
51°57'58.07"N, 5°39'25.31"E
0 references
51°49'34.14"N, 5°51'42.34"E
0 references
6662 PW
0 references
6702AA
0 references
6545 CJ
0 references
2132 NG
0 references
6500 HB
0 references
6525EN
0 references
3700 AJ
0 references
BriteN ontwikkelt producten voor vroege interventies ten behoeve van een gezonde cognitieve en metabole ontwikkeling, specifiek gericht op het reduceren van het risico voor de ontwikkeling van metabool syndroom en obesitas bij kinderen. Het projec... (Dutch)
0 references
BriteN develops early intervention products for healthy cognitive and metabolic development, specifically aimed at reducing the risk for the development of metabolic syndrome and childhood obesity. The projec... (English)
15 December 2021
0 references
Briten développe des produits d’intervention précoce pour un développement cognitif et métabolique sain, visant spécifiquement à réduire le risque de développement du syndrome métabolique et de l’obésité infantile. Le projec... (French)
15 December 2021
0 references
Briten entwickelt frühe Interventionsprodukte für eine gesunde kognitive und metabolische Entwicklung, die speziell darauf abzielt, das Risiko für die Entwicklung des Stoffwechselsyndroms und der Fettleibigkeit im Kindesalter zu reduzieren. Die Projec... (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00405
0 references